The other patient had a history of deep vein thrombosis and tested positive for anti-β2GPI IgA on admission, anti-β2GPI IgA and aCL IgG on discharge, and aCL IgG on follow-up. This evidence concerns the gene CD79A and deep vein thrombosis.